Learning Objectives:

  1. apply evidence-based surgical intervention for various stages and sites of head and neck cancer;
  2. the role of adjuvant or definitive radiation therapy in the treatment of the above based on literature;
  3. Be able to assess the role of chemotherapy use in the management of head and neck cancer in the neoadjuvant and concurrent radiotherapy settings.
Session date: 
08/26/2021 - 7:00am to 9:00am CDT
DCAM 1333
United States
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel Haraf, MD